BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 10525378)

  • 21. Vaginal and pelvic recurrence rates based on vaginal cuff length in patients with cervical cancer who underwent radical hysterectomies.
    Kim K; Cho SY; Park SI; Kim BJ; Kim MH; Choi SC; Ryu SY; Lee ED
    Eur J Surg Oncol; 2011 Sep; 37(9):824-7. PubMed ID: 21723690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
    Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
    Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.
    Werner-Wasik M; Schmid CH; Bornstein L; Ball HG; Smith DM; Madoc-Jones H
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1309-17. PubMed ID: 7635770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Wertheim-Meigs radical hysterectomy for cervical cancer stage IIB].
    Ivanov S
    Akush Ginekol (Sofiia); 2007; 46(2):22-4. PubMed ID: 17469447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postoperative radiotherapy for cervix cancer incidentally discovered after a simple hysterectomy for either benign conditions or noninvasive pathology.
    Smith KB; Amdur RJ; Yeung AR; Morris CG; Kirwan J; Morgan LS
    Am J Clin Oncol; 2010 Jun; 33(3):229-32. PubMed ID: 19806037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radical hysterectomy without adjuvant radiotherapy in patients with cervix carcinoma FIGO 2009 IB1, with or without positive Sedlis criteria.
    Haesen J; Salihi R; Van Gorp T; Van Nieuwenhuysen E; Han SN; Christiaens M; Van Rompuy AS; Waumans L; Neven P; Vergote I
    Gynecol Oncol; 2021 Sep; 162(3):539-545. PubMed ID: 34253389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: a retrospective study of 288 patients.
    Zheng M; Huang L; Liu JH; Xiong Y; Li JD; Huang X; He L; Ren YF; Wang HY
    J Surg Oncol; 2011 Oct; 104(5):480-5. PubMed ID: 21538358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjunctive radiotherapy after radical hysterectomy in high risk early stage cervical carcinoma. Assessment of morbidity and recurrences.
    Frigerio L; Busci L; Rabaiotti E; Mariani A
    Eur J Gynaecol Oncol; 1994; 15(2):132-7. PubMed ID: 8005143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early stage cervical cancer: Brachytherapy followed by type a hysterectomy versus type B radical hysterectomy alone, a retrospective evaluation.
    Lacorre A; Merlot B; Garabedian C; Narducci F; Chereau E; Resbeut M; Minsat M; Leblanc E; Houvenaeghel G; Lambaudie E
    Eur J Surg Oncol; 2016 Mar; 42(3):376-82. PubMed ID: 26725307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The value of adjuvant irradiation in lymphatic vessel invasion in patients with a cervical carcinoma in histopathological stage Ib and with negative lymph nodes].
    Vavra N; Sevelda P; Seifert M; Timar J; Kudielka I; Kucera H
    Strahlenther Onkol; 1992 Sep; 168(9):524-7. PubMed ID: 1411926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapy.
    Yessaian A; Magistris A; Burger RA; Monk BJ
    Gynecol Oncol; 2004 Jul; 94(1):61-6. PubMed ID: 15262120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
    Aoki Y; Sasaki M; Watanabe M; Sato T; Tsuneki I; Aida H; Tanaka K
    Gynecol Oncol; 2000 May; 77(2):305-9. PubMed ID: 10785483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stage IB and IIA cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy.
    Schorge JO; Molpus KL; Koelliker D; Nikrui N; Goodman A; Fuller AF
    Gynecol Oncol; 1997 Jul; 66(1):31-5. PubMed ID: 9234917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolated full-thickness cervical stromal invasion warrants post-hysterectomy pelvic radiotherapy in FIGO stages IB-IIA uterine cervical carcinoma.
    Moon SH; Wu HG; Ha SW; Lee HP; Kang SB; Song YS; Park NH; Kim JW; Park IA; Kim BH
    Gynecol Oncol; 2007 Jan; 104(1):152-7. PubMed ID: 16935323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
    Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy versus radiotherapy versus observation for high-risk cervical carcinoma after radical hysterectomy: A randomized, prospective, multicenter trial.
    Lahousen M; Haas J; Pickel H; Hackl A; Kurz C; Ogris H; Stummvoll W; Winter R
    Gynecol Oncol; 1999 May; 73(2):196-201. PubMed ID: 10329034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement.
    Mariani A; Webb MJ; Keeney GL; Calori G; Podratz KC
    Gynecol Oncol; 2001 Oct; 83(1):72-80. PubMed ID: 11585416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tailoring the field and indication of adjuvant pelvic radiation for patients with FIGO stage Ib lymph nodes-negative cervical carcinoma following radical surgery based on the GOG score--a pilot study.
    Rushdan MN; Tay EH; Khoo-Tan HS; Lee KM; Low JH; Ho TH; Yam KL
    Ann Acad Med Singap; 2004 Jul; 33(4):467-72. PubMed ID: 15329758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Class II radical hysterectomy for stage I-IIA cervix cancer: prognostic factors associated to recurrence and survival in a northeast Brazil experience.
    Bezerra AL; Martins MR; Bezerra SM; Figueiroa JN; Batista TP
    J Surg Oncol; 2011 Sep; 104(3):255-9. PubMed ID: 21465491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy.
    Wright JD; Grigsby PW; Brooks R; Powell MA; Gibb RK; Gao F; Rader JS; Mutch DG
    Cancer; 2007 Sep; 110(6):1281-6. PubMed ID: 17654664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.